The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trial.

The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trial.

Lymphatic filariasis has remained endemic in Fiji despite repeated mass drug administration using the well-established and safe combination of diethylcarbamazine and albendazole (DA) since 2002. In certain settings the addition of ivermectin to this combination (IDA) remains a safe strategy and is m...

Full description

Bibliographic Details
Main Authors:	Myra Hardy, Josaia Samuela, Mike Kama, Meciusela Tuicakau, Lucia Romani, Margot J Whitfeld, Christopher L King, Gary J Weil, Anneke C Grobler, Leanne J Robinson, John M Kaldor, Andrew C Steer
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2020-03-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	https://doi.org/10.1371/journal.pntd.0008106

Similar Items

Community control strategies for scabies: A cluster randomised noninferiority trial.
by: Myra Hardy, et al.
Published: (2021-11-01)

An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia.
by: Taniawati Supali, et al.
Published: (2021-03-01)

An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India.
by: Purushothaman Jambulingam, et al.
Published: (2021-02-01)

Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
by: Peter U Fischer, et al.
Published: (2017-01-01)

Pharmacokinetics of Moxidectin combined with Albendazole or Albendazole plus Diethylcarbamazine for Bancroftian Filariasis.
by: Yashpal S Chhonker, et al.
Published: (2023-08-01)

Scabies and impetigo prevalence and risk factors in Fiji: a national survey.
by: Lucia Romani, et al.
Published: (2015-03-01)

A comparison of the efficacy of single doses of albendazole, ivermectin, and diethylcarbamazine alone or in combinations against Ascaris and Trichuris spp.
by: Belizario V.Y., et al.
Published: (2003-01-01)

A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis.
by: Nicholas O Opoku, et al.
Published: (2023-05-01)

Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire.
by: Constant Edi, et al.
Published: (2019-05-01)

Prevention of bacterial complications of scabies using mass drug administration: A population-based, before-after trial in Fiji, 2018–2020
by: Li Jun Thean, et al.
Published: (2022-05-01)

A Retrospective Study of the Efficacy of Albendazole and Diethylcarbamazine for the Treatment of Human Toxocariasis
by: Jean-François Magnaval, et al.
Published: (2022-07-01)

The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea.
by: Gary J Weil, et al.
Published: (2008-01-01)

Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study.
by: Christine L Dubray, et al.
Published: (2020-06-01)

Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study
by: Christabel Khaemba, et al.
Published: (2021-03-01)

One versus two doses of ivermectin-based mass drug administration for the control of scabies: A cluster randomised non-inferiority trial.
by: Susanna J Lake, et al.
Published: (2023-03-01)

Community perspectives on scabies, impetigo and mass drug administration in Fiji: A qualitative study.
by: Elke Mitchell, et al.
Published: (2020-12-01)

Detection of resistance of gastrointestinal nematodes to albendazole and ivermectin in goats
by: Hassan Basri, Basripuzi Nurul Hayyan, et al.
Published: (2010)

Prospective surveillance for invasive Staphylococcus aureus and group A Streptococcus infections in a setting with high community burden of scabies and impetigo
by: Li Jun Thean, et al.
Published: (2021-07-01)

Egg excretion patterns of soil-transmitted helminth infections in humans following albendazole-ivermectin and albendazole treatment.
by: Sophie Welsche, et al.
Published: (2024-03-01)

Detection of Gastrointestinal Nematode Populations Resistant to Albendazole and Ivermectin in Sheep
by: Jaime Mondragón-Ancelmo, et al.
Published: (2019-10-01)

Exploration of a simplified clinical examination for scabies to support public health decision-making.
by: Michael Marks, et al.
Published: (2018-12-01)

In vitro evaluation of ivermectin, moxidectin, albendazole and pyrantel against cyathostomins of horses
by: Marcelo Beltrão Molento, et al.
Published: (2017-11-01)

Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety study.
by: Khalfan A Mohammed, et al.
Published: (2008-01-01)

Dangerous reactions to treatment of onchocerciasis with diethylcarbamazine.
by: Bryceson, A, et al.
Published: (1977)

Efficacy of Novel Formulations of Ivermectin and Albendazole in Parasitic Infections of Sheep in the Altai Mountains of Russia
by: Victor Alexeevich Marchenko, et al.
Published: (2021-05-01)

Recurrent hemorrhagic pericardial effusion and tamponade due to filariasis successfully treated with ivermectin and albendazole
by: Santosh Kumar Sinha, et al.
Published: (2015-01-01)

Feasibility and safety of mass drug coadministration with azithromycin and ivermectin for the control of neglected tropical diseases: a single-arm intervention trial
by: Lucia Romani, PhD, et al.
Published: (2018-10-01)

Analysis of the population-level impact of co-administering ivermectin with albendazole or mebendazole for the control and elimination of Trichuris trichiura
by: Turner, H, et al.
Published: (2016)

Defining the need for public health control of scabies in Solomon Islands.
by: Susanna J Lake, et al.
Published: (2021-02-01)

Analysis of the population-level impact of co-administering ivermectin with albendazole or mebendazole for the control and elimination of Trichuris trichiura
by: Hugo C. Turner, et al.
Published: (2016-06-01)

Synthesis and Clinical Examination of Novel Formulations of Ivermectin, Albendazole and Niclosamide for the Treatment of Equine Gastrointestinal Helminthoses
by: Victor Alevichxee Marchenko, et al.
Published: (2023-03-01)

Disseminated strongyloidiasis complicated by alveolar hemorrhage, meningitis, and septic shock treated with albendazole and subcutaneous ivermectin
by: A. Balkhair, et al.
Published: (2019-09-01)

Different gut microbial communities correlate with efficacy of albendazole-ivermectin against soil-transmitted helminthiases
by: Pierre H. H. Schneeberger, et al.
Published: (2022-02-01)

A case of follicular cystitis treated successfully with diethylcarbamazine
by: Maduwe Gedara Sagara Ruwan Kumara, et al.
Published: (2021-04-01)

Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission.
by: Paul E Simonsen, et al.
Published: (2010-06-01)

Single-dose diethylcarbamazine in the control of periodic brugian filariasis in Peninsular Malaysia
by: Hakim, S.L., et al.
Published: (1995)

Diethylcarbamazine, TRP channels and Ca2+ signaling in cells of the Ascaris intestine
by: Paul D. E. Williams, et al.
Published: (2022-12-01)

Long-term outcomes of ivermectin-albendazole versus albendazole alone against soil-transmitted helminths: Results from randomized controlled trials in Lao PDR and Pemba Island, Tanzania.
by: Ladina Keller, et al.
Published: (2021-06-01)

Pharmacokinetics, feasibility and safety of co-administering azithromycin, albendazole, and ivermectin during mass drug administration: A review.
by: Scott McPherson, et al.
Published: (2023-06-01)

Correction: Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania.
by: Inge Kroidl, et al.
Published: (2016-08-01)